Stock INKT MINK THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart MiNK Therapeutics, Inc.

Equities

INKT

US6036931029

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-06-04 pm EDT 		5-day change 1st Jan Change
0.9951 USD +0.02% Intraday chart for MiNK Therapeutics, Inc. +5.86% -7.00%
May. 22 MiNK Therapeutics, Inc. Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting CI
May. 14 Transcript : MiNK Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MINK THERAPEUTICS, INC. Stock MiNK Therapeutics, Inc.
 39.14M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 56.65B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 39.44B
LONZA GROUP AG Stock Lonza Group AG
 39.03B
CELLTRION, INC. Stock Celltrion, Inc.
 26.86B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.75B
  1. Stock Market
  2. Equities
  3. INKT Stock
  4. Charts MiNK Therapeutics, Inc.
  5. Sector Chart